GladGlad I sold out at 42.00. But I think the pancreatic trial is going to succeed. Years ago I was in Lorus Therapeutics (now Aptose) and I made a lot of money going from .34 to 2.50 +. Jim Wright was CEO. NewLink is mirroring them with the exception that NewLink has more enrolled patients (777 I think) which makes a very big difference. This is very risky, but if you can pick up less than 29.00 then I think you can make money. Good luck to all.